Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13221 | 1.00 | RAB9A (0.32) | RAB9AELANEPCSK9L3MBTL1NOS1 | |
| SCHEMBL8121 | 1.00 | RAB9A (0.32) | RAB9AELANEPCSK9L3MBTL1NOS1 | |
| SCHEMBL2343819 | 0.89 | ELANE (0.35) | ELANENOS1 | |
| SCHEMBL17560519 | 0.89 | ELANE (0.35) | ELANENOS1 | |
| SCHEMBL17654422 | 0.89 | RAB9A (0.32) | RAB9AELANEPCSK9L3MBTL1NOS1 | |
| SCHEMBL2127300 | 0.89 | ELANE (0.35) | ELANENOS1 | |
| SCHEMBL13518677 | 0.89 | RAB9A (0.32) | RAB9AELANEPCSK9L3MBTL1NOS1 | |
| SCHEMBL13518680 | 0.89 | RAB9A (0.32) | RAB9AELANEPCSK9L3MBTL1NOS1 | |
| SCHEMBL25504021 | 0.89 | ELANE (0.32) | ELANENOS1 | |
| SCHEMBL24177802 | 0.89 | PCSK9 (0.33) | ELANEPCSK9NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 811 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10155009-B2 | Polyion complex of poly(L-arginine) segment-containing block copolymer and polyanionic polymer | General Incorporated Association Tsukuba Global Innovation Promotion Agency (JP) | 2018-12-18 | — | — | US | claimed |
| US-20180085395-A1 | POLYION COMPLEX OF POLY(L-ARGININE) SEGMENT-CONTAINING BLOCK COPOLYMER AND POLYANIONIC POLYMER | General Incorporated Association Tsukuba Global Innovation Promotion Agency (JP) | 2018-03-29 | — | — | US | claimed |
| EP-3284474-A1 | POLYION COMPLEX OF POLY(L-ARGININE) SEGMENT-CONTAINING BLOCK COPOLYMER AND POLYANIONIC POLYMER | General Incorporated Association Tsukuba Global Innovation Promotion Agency (JP) | 2018-02-21 | — | — | EP | claimed |
| EP-4720058-A2 | BIFUNCTIONAL DEGRADERS AND USES THEREOF | Casma Therapeutics, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12590083-B2 | Inhibitors of spinster homolog 2 (SPNS2) for use in therapy | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2026-03-31 | — | — | US | disclosed |
| US-12544359-B2 | 1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitors | Infex Therapeutics Limited (GB) | 2026-02-10 | — | — | US | disclosed |
| US-20260035357-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCE INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12540161-B2 | Linkers | BICYCLETX LIMITED (GB) | 2026-02-03 | — | — | US | disclosed |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| US-20260015337-A1 | COMPOUNDS FOR TREATMENT A CORONAVIRUS INFECTION | TRAWSFYNYDD THERAPEUTICS INC (US) | 2026-01-15 | — | — | US | disclosed |
| EP-4321524-B1 | LIPID AND COMPOSITION | SOGO PHARM (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-5856309-A | TREATING OSTEOPOROSIS, INFLAMMATION OR A DISEASE WHICH IS DUE TO A THROMBOEMBOLIC EVENT | BOEHRINGER MANNHEIM GMBH (DE) | 1999-01-05 | — | — | US | disclosed |
| EP-0833825-A4 | 6-CARBOXAMIDO DIHYDROPYRAN DERIVATIVES | BIOTA SCIENT MANAGEMENT (AU) | 1998-10-07 | — | — | EP | disclosed |
| US-5763483-A | NEURAMINIDASE INHIBITOR TREATING INFLUENZA VIRUS INFECTION; OSELTAMIVIR OR THE FREE ACID THEREOF; FDA ORANGE BOOK LISTED PATENT FOR OSELTAMIVIR PHOSPHATE | GILEAD SCIENCES, INC. (US) | 1998-06-09 | — | — | US | disclosed |
| EP-0833825-A1 | 6-CARBOXAMIDO DIHYDROPYRAN DERIVATIVES | BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) | 1998-04-08 | — | — | EP | disclosed |
| WO-1998007420-A1 | NEUROPEPTIDE-Y LIGANDS | AGOURON ACQUISITION CORP. (US) | 1998-02-26 | — | — | WO | disclosed |
| EP-0759917-A1 | NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES | GILEAD SCIENCES, INC. (US) | 1997-03-05 | — | — | EP | disclosed |
| WO-1996026933-A9 | NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES | — | 1996-11-28 | — | — | WO | disclosed |
| WO-1996036628-A1 | 6-CARBOXAMIDO DIHYDROPYRAN DERIVATIVES | BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) | 1996-11-21 | — | — | WO | disclosed |
| WO-1996026933-A1 | NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES | GILEAD SCIENCES, INC. (US) | 1996-09-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12544359-B2 | 1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitors | CBR1, CBR3, SRR | RAB9A 2160/4885ELANE 3408/4885PCSK9 1278/4885 |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | NSUN3, BCAT1, SLC43A1 | RAB9A 1211/4885ELANE 2120/4885PCSK9 3587/4885 |
| US-20260015337-A1 | COMPOUNDS FOR TREATMENT A CORONAVIRUS INFECTION | ACE2, ACE, TMPRSS2 | RAB9A 1612/4885ELANE 1542/4885PCSK9 133/4885 |
| US-10155009-B2 | Polyion complex of poly(L-arginine) segment-containing block copolymer and polyanionic polymer | ARG1, NOS2, ARG2 | RAB9A 4637/4885ELANE 2025/4885PCSK9 4231/4885 |
| US-20180085395-A1 | POLYION COMPLEX OF POLY(L-ARGININE) SEGMENT-CONTAINING BLOCK COPOLYMER AND POLYANIONIC POLYMER | ARG1, NOS2, ARG2 | RAB9A 4637/4885ELANE 2025/4885PCSK9 4231/4885 |
| US-12590083-B2 | Inhibitors of spinster homolog 2 (SPNS2) for use in therapy | SPNS2, SLC20A2, S1PR2 | RAB9A 1729/4885ELANE 3151/4885PCSK9 216/4885 |
| US-20260035357-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | CCR10, CCR1, CCR3 | RAB9A 748/4885ELANE 1336/4885PCSK9 2450/4885 |
| US-12540161-B2 | Linkers | ADM2, CDA, DCTD | RAB9A 3905/4885ELANE 4271/4885PCSK9 3833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.